These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27907168)

  • 1. Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis.
    Zhou LT; Lv LL; Pan MM; Cao YH; Liu H; Feng Y; Ni HF; Liu BC
    PLoS One; 2016; 11(12):e0167334. PubMed ID: 27907168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
    Lobato GR; Lobato MR; Thomé FS; Veronese FV
    Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
    Hsu CY; Xie D; Waikar SS; Bonventre JV; Zhang X; Sabbisetti V; Mifflin TE; Coresh J; Diamantidis CJ; He J; Lora CM; Miller ER; Nelson RG; Ojo AO; Rahman M; Schelling JR; Wilson FP; Kimmel PL; Feldman HI; Vasan RS; Liu KD; ;
    Kidney Int; 2017 Jan; 91(1):196-203. PubMed ID: 28029431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.
    Sokolski M; Zymliński R; Biegus J; Siwołowski P; Nawrocka-Millward S; Todd J; Yerramilli MR; Estis J; Jankowska EA; Banasiak W; Ponikowski P
    Eur J Heart Fail; 2017 Jun; 19(6):760-767. PubMed ID: 28133864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis.
    Taşdemir M; Fuçucuoğlu D; Küçük SH; Erol M; Yiğit Ö; Bilge I
    Clin Exp Nephrol; 2018 Feb; 22(1):133-141. PubMed ID: 28653226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.
    Park M; Hsu CY; Go AS; Feldman HI; Xie D; Zhang X; Mifflin T; Waikar SS; Sabbisetti VS; Bonventre JV; Coresh J; Nelson RG; Kimmel PL; Kusek JW; Rahman M; Schelling JR; Vasan RS; Liu KD; ;
    Clin J Am Soc Nephrol; 2017 May; 12(5):761-771. PubMed ID: 28254771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Urinary Calprotectin, NGAL and KIM-1 in Chronic Kidney Disease.
    Seibert FS; Sitz M; Passfall J; Haesner M; Laschinski P; Buhl M; Bauer F; Babel N; Pagonas N; Westhoff TH
    Kidney Blood Press Res; 2018; 43(4):1255-1262. PubMed ID: 30078006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.
    Satirapoj B; Pooluea P; Nata N; Supasyndh O
    J Diabetes Complications; 2019 Sep; 33(9):675-681. PubMed ID: 31227289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
    Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Ix JH; Jogalekar MP; Coca S; Waikar SS; Shlipak MG; Warady BA; Vasan RS; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S; ;
    J Am Soc Nephrol; 2021 Oct; 32(10):2664-2677. PubMed ID: 34544821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for Chronic Kidney Disease Associated with High Salt Intake.
    Hosohata K
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28973979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Foster MC; Coresh J; Bonventre JV; Sabbisetti VS; Waikar SS; Mifflin TE; Nelson RG; Grams M; Feldman HI; Vasan RS; Kimmel PL; Hsu CY; Liu KD;
    Clin J Am Soc Nephrol; 2015 Nov; 10(11):1956-63. PubMed ID: 26350438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women.
    Scherzer R; Lin H; Abraham A; Thiessen-Philbrook H; Parikh CR; Bennett M; Cohen MH; Nowicki M; Gustafson DR; Sharma A; Young M; Tien P; Jotwani V; Shlipak MG
    Nephrol Dial Transplant; 2016 Sep; 31(9):1478-85. PubMed ID: 26754833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as early biomarkers for predicting vancomycin-associated acute kidney injury: a prospective study.
    Pang HM; Qin XL; Liu TT; Wei WX; Cheng DH; Lu H; Guo Q; Jing L
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4203-4213. PubMed ID: 29028077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview.
    Laurentino MR; Parente Filho SLA; Parente LLC; da Silva Júnior GB; Daher EF; Lemes RPG
    Ann Hematol; 2019 Dec; 98(12):2653-2660. PubMed ID: 31641850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.